OICR Biolab: Droplets for Cancer Detection in Liquid Biopsy

OICR Biolab: Droplets for Cancer Detection in Liquid Biopsy

When and Where

Date: Thursday, April 19, 2018 - Thursday, April 19, 2018 (1 day)
Location:

Registration Contact

Dr. Vanya Peltekova
Send Email »

Liquid biopsy, a noninvasive technique for capture and isolation of cell-free circulating tumor DNA (cfDNA) is a rapidly emerging field that address the unmet clinical needs in cancer diagnostics, prognosis and treatment. The seminar will introduce droplet based ddPCR assays and applications for accurate and sensitive detection of genetic variants and tumor-associated aberrations.

Date: April 19th, 2018 Time: 3 - 4 pm BR 5-20/21 (max 50 people)

Presenter: Claude Lachance, PH.D., BioRad

Liquid biopsy, a noninvasive technique for capture and isolation of plasma DNA, is a rapidly emerging field that addresses the unmet clinical need in cancer diagnostics based on cell-free circulating tumor DNA (ctDNA) and cell-free plasma DNA (cfDNA). The merge between liquid biopsy and droplet-based ddPCR has been rapidly expanding in the cancer diagnostics and pathology space due to its application for accurate and sensitive detection of biomarkers and genetic variants from patients with cancer. Email Vanya Peltekova to register.

The learning objectives are: Learning Objectives:

  • • What is Droplet digital PCR (ddPCR) technology?
  • • ddPCR in cancer detection and monitoring
  • • ddPCR assays for ctDNA genotyping (plasma genotyping)
  • • microRNA – potential for liquid biopsy
  • Pathologists and Researchers who are interested in being part of the OMPRN: